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Background: Patients with severe symptomatic aortic valve stenosis (AS) at high surgical risk can now be treated with transcatheter aortic 
valve implantation (TAVI). The mortality of patients on the waiting list for this procedure is not well characterized. We assessed the incidence and 
predictors of mortality of patients waiting for TAVI in a large single center experience.
Methods: All accepted candidates for TAVI from January 2005 to July 2009 were included. Baseline clinical, echocardiographic and invasive 
characteristics were recorded. Waiting time was defined as the time from decision to implant to the time of death or TAVI. Univariate and multivariate 
predictors of mortality were determined.
Results: During the study period, 267 patients were accepted for TAVI. Mean age was 81.5±8.4 years (53% males). Most were in NYHA II or more 
and 30% CCS II or more. Mean glomerular filtration rate (GFR) was 56.3±23.7ml/min. Mean aortic valve area and gradient was 0.63±0.17cm2 
and 44.3±16.0mmHg respectively. 27% of patients had pulmonary hypertension (PH) (mean pulmonary arterial pressure>25mmHg). Mean left 
ventricular ejection fraction (LVEF) was 53.9±14.4%. The median waiting time for TAVI was 106.8 days. Twenty-eight (10.5%) patients died while 
waiting, of which 60% occurred suddenly. Impaired LVEF, reduced GFR and associated pulmonary hypertension were univariate predictors of 
mortality. PH was the only independent predictor of mortality in multivariate analysis.
Conclusions: Patients declined conventional surgery and accepted for TAVI are at high risk of dying while awaiting treatment. The presence of 
associated pulmonary hypertension is an independent predictor of mortality and should be considered during triaging.
